Literature DB >> 22322738

Prospective analysis of reasons for non-enrollment in a phase III randomized controlled trial.

Vedang Murthy1, Kasturi R Awatagiri, Pramod K Tike, Sarbani Ghosh-Laskar, Tejpal Gupta, Ashwini Budrukkar, Mandar S Deshpande, Devendra A Chaukar, Gouri H Pantavaidya, Jai Prakash Agarwal.   

Abstract

AIM: This study aims to provide information on the accrual rate and to identify the reasons for non-enrollment of oral cancer patients into a clinical trial. SETTING AND
DESIGN: Prospective study conducted at the Tertiary Cancer Centre (India).
MATERIALS AND METHODS: Patients eligible and screened for the oral cancer adjuvant therapy (OCAT) were logged prospectively and reasons for non-enrollment were documented which were broadly divided into patient and trial related. STATISTICAL ANALYSIS USED: Demographic characteristics of the non-enrolees were compared with the enrolled. Factors predicting non-enrollment were analyzed using multivariate logistic regression test.
RESULTS: A total of 1335 patients with locally advanced cancer of the oral cavity were screened of whom 498 (37%) could be enrolled. Among non enrolled 837 patients, 182 (22%) had the trial-related reasons and 655 (78%) had patient-related reasons. Most important patient-related reasons were patients' preference of taking treatment closer to their native place (26.2%), lack of interest (16.8%) in trial participation. Anticipated poor compliance to treatment (5.9%) and follow-up (6.6%), inability to start treatment in time (6.2%) were important trial-related reasons for non-enrollment. Multivariate analysis identified the genders (female), education (illiterate), occupation (laborer) and non availability of support system in the city as significant predictors of non-enrollment.
CONCLUSIONS: Both trial design and patient factors were important causes of non enrollment in eligible patients. Patients' need for being closer to home and refusal to participate were the most common reasons for non-enrollment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22322738     DOI: 10.4103/0973-1482.92221

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  4 in total

1.  Impact of Eligibility Criteria on Participant Enrollment for a Randomized Clinical Trial of Gonorrhea Treatment.

Authors:  Jill E Long; Michael R Wierzbicki; Edward W Hook
Journal:  Sex Transm Dis       Date:  2017-06       Impact factor: 2.830

2.  The willingness to participate in biomedical research involving human beings in low- and middle-income countries: a systematic review.

Authors:  Joyce L Browne; Connie O Rees; Johannes J M van Delden; Irene Agyepong; Diederick E Grobbee; Ama Edwin; Kerstin Klipstein-Grobusch; Rieke van der Graaf
Journal:  Trop Med Int Health       Date:  2019-01-08       Impact factor: 2.622

3.  An Audit of Protocol Deviations Submitted to an Institutional Ethics Committee of a Tertiary Care Hospital.

Authors:  Sharmila V Jalgaonkar; Shruti S Bhide; Raakhi K Tripathi; Yashashri C Shetty; Padmaja A Marathe; Janhavi Katkar; Urmila M Thatte
Journal:  PLoS One       Date:  2016-01-06       Impact factor: 3.240

4.  Will they participate? Predicting patients' response to clinical trial invitations in a pediatric emergency department.

Authors:  Yizhao Ni; Andrew F Beck; Regina Taylor; Jenna Dyas; Imre Solti; Jacqueline Grupp-Phelan; Judith W Dexheimer
Journal:  J Am Med Inform Assoc       Date:  2016-04-27       Impact factor: 4.497

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.